EMEA-001786-PIP01-15-M02

Table of contents

Key facts

Invented name
Ervebo
Active substance
Ebola Zaire Vaccine (rVSV∆G-ZEBOV-GP, live)
Therapeutic area
Vaccines
Decision number
P/0429/2021
PIP number
EMEA-001786-PIP01-15-M02
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Prevention of Ebola virus disease
Route(s) of administration
Intramuscular use
Contact for public enquiries
Merck Sharp & Dohme (Europe) Inc.

E-mail: pip.information@merck.com
Tel.: +33 180464738

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating